Evidence map›Paper›PMID 27457085›Full record

ReviewCurrent cardiology reports2016

Is Heart Rate a Norepiphenomenon in Heart Failure?

Mark Hensey, James O'Neill

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark HenseyConnolly Hospital Blanchardstown, Blanchardstown, Dublin 15, Dublin, Ireland.
James O'NeillConnolly Hospital Blanchardstown, Blanchardstown, Dublin 15, Dublin, Ireland. jimoneill@rcsi.ie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been an increased focus on heart rate as a target in the management of cardiovascular disease and more specifically in heart failure with preserved ejection fraction in recent years with several studies showing the benefit of a lower resting heart rate on outcomes. This review paper examines the pathophysiology behind the benefits of lowering heart rate in heart failure and also the evidence for and against the pharmacological agents available to achieve this.

Indexed as

Adrenergic AntagonistsAmiodaroneBenzazepinesDepression, ChemicalDigoxinEvidence-Based MedicineHeart FailureHeart RateHumansIvabradineAdrenergic AntagonistsAmiodaroneBenzazepinesDigoxinIvabradineHeart failureHeart rateNorepiphenomenon

Identifiers

PMID27457085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.